Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
World Journal of Gastrointestinal Pharmacology and Therapeutics|May 20, 2024
Treatment endpoints in ulcerative colitis: Does one size fit all?Nikola Mitrev, Viraj KariyawasamWorld Journal of Clinical Cases|April 18, 2022
Dual biologic therapy with ocrelizumab for multiple sclerosis and vedolizumab for Crohn's disease: A case report and review of literatureMichael Au, Nikola Mitrev, Rupert W Leong, et al.Case Reports in Gastroenterology|October 9, 2025
Minimally Invasive Full-Thickness Resection of a Non-Lifting Adenoma in an Ulcerative Colitis Patient Using OVESCO: A Case ReportFei Yang Pan, Rupert Leong, Saurabh Gupta, et al.BMJ Open Gastroenterology|February 13, 2021
Depression, anxiety and stress among patients with inflammatory bowel disease during the COVID-19 pandemic: Australian national surveyMadiha Cheema, Nikola Mitrev, Leanne Hall, et al.Expert Opinion on Drug Safety|April 27, 2019
Safety of drugs used for the treatment of Crohn's diseaseAviv Pudipeddi, Viraj Kariyawasam, Craig Haifer, et al.The American Journal of Gastroenterology|January 26, 2024
Biological Agents in the Treatment of Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) StudyJohn David Chetwood, Yanna Ko, Aviv Pudipeddi, et al.Crohn'S & Colitis 360|January 6, 2025
Development and Validation of a Scoring System to Predict 2-Year Clinical Remission in Ulcerative Colitis Patients on VedolizumabThanaboon Chaemsupaphan, Aviv Pudipeddi, Huiyu Lin, et al.Journal of Crohn'S & Colitis|March 26, 2014
Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitisRupert W L Leong, Tony Huang, Yanna Ko, et al.Therapeutic Advances in Gastroenterology|January 22, 2026
Vedolizumab in inflammatory bowel disease: pharmacokinetics and the role of immunomodulator co-therapyAviv Pudipeddi, Thanaboon Chaemsupaphan, Arteen Arzivian, et al.Liver International : Official Journal of the International Association for the Study of the Liver|November 29, 2016
Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohortKen Liu, Ruoxi Wang, Viraj Kariyawasam, et al.Pageof 3